Key facts
- It has raised $4.0M across 5 recorded rounds; the latest was Seed Round ($1.5M) in Dec 2025.
- Pace Surgical has filed 4 Form Ds with the SEC since 2023, most recently Jul 2025 ($1.2M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Pace Surgical
Funding rounds
5 roundsAbout Pace Surgical
Manufacturer of orthopedic fixation devices designed to address foot and ankle trauma and reconstruction needs. The company offers anatomically specific implants including compression screws with proprietary titanium thread forms, variable locking plating systems tailored to conditions such as fractures, deformity correction, arthrodesis, and syndesmosis, low-profile designs to minimize irritation, and pathology-specific configurations, enabling orthopedic surgeons and podiatrists to achieve precise anatomical fit, improved patient comfort, and enhanced post-operative stability.
- Sector
- Healthcare
- HQ
- Malvern, PA, United States
- Founded
- 2023
- Website
- pace-surgical.com/
- Ownership
- Privately Held (backing)
Pace Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pace Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pace Surgical in its N-PORT filings yet. We sweep new filings monthly.